T3	Subject 46 95	a patient with acute promyleocytic leukemia (APL)
T6	Treatment 96 171	within 10 days of treatment with ATRA at a dose of 40 mg orally twice daily
T4	Effect 29 42	scrotal ulcer
T8	Time_elapsed 96 110	within 10 days
T9	Drug 129 133	ATRA
T10	Dosage 147 152	40 mg
T11	Route 153 159	orally
T12	Freq 160 171	twice daily
T13	Treat-Disorder 61 95	acute promyleocytic leukemia (APL)
T5	Adverse_event 14 25	development
E1	Adverse_event:T5